» Articles » PMID: 10607679

The Presence of an RHD Pseudogene Containing a 37 Base Pair Duplication and a Nonsense Mutation in Africans with the Rh D-negative Blood Group Phenotype

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1999 Dec 23
PMID 10607679
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Antigens of the Rh blood group system are encoded by 2 homologous genes, RHD and RHCE, that produce 2 red cell membrane proteins. The D-negative phenotype is considered to result, almost invariably, from homozygosity for a complete deletion of RHD. The basis of all PCR tests for predicting fetal D phenotype from DNA obtained from amniocytes or maternal plasma is detection of the presence of RHD. These tests are used in order to ascertain the risk of hemolytic disease of the newborn. We have identified an RHD pseudogene (RHD psi) in Rh D-negative Africans. RHDpsi contains a 37 base pair (bp) insert in exon 4, which may introduce a stop codon at position 210. The insert is a sequence duplication across the boundary of intron 3 and exon 4. RHDpsi contains another stop codon in exon 6. The frequency of RHDpsi in black South Africans is approximately 0.0714. Of 82 D-negative black Africans, 66% had RHDpsi, 15% had the RHD-CE-D hybrid gene associated with the VS+ V- phenotype, and only 18% completely lacked RHD. RHDpsi is present in about 24% of D-negative African Americans and 17% of D-negative South Africans of mixed race. No RHD transcript could be detected in D-negative individuals with RHDpsi, probably as a result of nonsense-mediated mRNA decay. Existing PCR-based methods for predicting D phenotype from DNA are not suitable for testing Africans or any population containing a substantial proportion of people with African ethnicity. Consequently, we have developed a new test that detects the 37 bp insert in exon 4 of RHDpsi. (Blood. 2000; 95:12-18)

Citing Articles

Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort.

Gilstrop Thompson M, Xu W, Moore B, Wang T, Sun N, Pewar H Obstet Gynecol. 2024; 145(2):211-216.

PMID: 39591628 PMC: 11731044. DOI: 10.1097/AOG.0000000000005794.


Molecular Background of RhD-positive and RhD-negative Phenotypes in a Saudi Population.

Alalshaikh M, Alsughayir A, Alsaif A, Ababtain S, Aloyouni S, Aldilaijan K Saudi J Med Med Sci. 2024; 12(3):210-215.

PMID: 39055072 PMC: 11268538. DOI: 10.4103/sjmms.sjmms_664_23.


Characterization of Blood Group Variants in an Omani Population by Comparison of Whole Genome Sequencing and Serology.

Haffener P, Al-Riyami A, Al-Zadjali S, Al-Rawahi M, Al Hosni S, Al Marhoobi A bioRxiv. 2024; .

PMID: 38948735 PMC: 11212902. DOI: 10.1101/2024.06.17.599396.


Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden.

Pardi C, Hellberg A, Isakson P Blood Transfus. 2024; 22(5):387-394.

PMID: 38814881 PMC: 11390609. DOI: 10.2450/BloodTransfus.741.


Two Cases of Anti-D Alloimmunization in D-Negative Thai Patients as a Result of the Asian-Type DEL on Transfused Red Cells.

Suksard K, Luangtrakool K, Rungroung T, Chamsai S, Saetam P, Kittisares K Transfus Med Hemother. 2024; 51(2):122-125.

PMID: 38584693 PMC: 10996056. DOI: 10.1159/000533625.